Literature DB >> 18510884

The value of prognostic indices for pneumonia.

Jennie Johnstone1, Sumit R Majumdar, Thomas J Marrie.   

Abstract

One of the most important decisions in the management of community-acquired pneumonia is deciding the care site, which affects morbidity, mortality, and costs. Clinical judgment alone is difficult and imprecise. The Pneumonia Severity Index score and the CURB-65 (confusion, urea nitrogen, respiratory rate, blood pressure, 65 years of age and older) score are validated prognostic indices to predict mortality, and they can identify low-risk patients who may be eligible for outpatient management. However, limitations of the scoring systems preclude their isolated use, and they can only be recommended as an aid to guide hospital admission decisions. The Pneumonia Severity Index score is slightly better at identifying the lowest risk patients, whereas CURB-65 is much simpler to use. As an adjunct to clinical judgment, we consider CURB-65 to be the most useful prognostic index for identifying low-risk patients.

Entities:  

Year:  2008        PMID: 18510884     DOI: 10.1007/s11908-008-0036-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  2004 update of BTS pneumonia guidelines: what's new?

Authors:  J T Macfarlane; D Boldy
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

3.  The Pneumonia Severity Index score: time to move to a prospective study of patients with community-acquired pneumonia who are discharged from emergency departments to be managed on an ambulatory basis.

Authors:  Thomas J Marrie
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

4.  A prediction rule for elderly primary-care patients with lower respiratory tract infections.

Authors:  J Bont; E Hak; A W Hoes; M Schipper; F G Schellevis; T J M Verheij
Journal:  Eur Respir J       Date:  2007-01-10       Impact factor: 16.671

5.  Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial.

Authors:  Donald M Yealy; Thomas E Auble; Roslyn A Stone; Judith R Lave; Thomas P Meehan; Louis G Graff; Jonathan M Fine; D Scott Obrosky; Maria K Mor; Jeff Whittle; Michael J Fine
Journal:  Ann Intern Med       Date:  2005-12-20       Impact factor: 25.391

6.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Authors:  Jose Labarere; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Thomas E Auble; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

7.  Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.

Authors:  Bertrand Renaud; Eva Coma; Jose Labarere; Jan Hayon; Pierre-Marie Roy; Hélène Boureaux; Fabienne Moritz; Jean François Cibien; Thomas Guérin; Emmanuel Carré; Armelle Lafontaine; Marie Pierre Bertrand; Aline Santin; Christian Brun-Buisson; Michael J Fine; Eric Roupie
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

8.  Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome. The British Thoracic Society and the Public Health Laboratory Service.

Authors: 
Journal:  Q J Med       Date:  1987-03

9.  Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia.

Authors:  C M Coley; Y H Li; A R Medsger; T J Marrie; M J Fine; W N Kapoor; J R Lave; A S Detsky; M C Weinstein; D E Singer
Journal:  Arch Intern Med       Date:  1996-07-22

10.  Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

Authors:  S J Atlas; T I Benzer; L H Borowsky; Y Chang; D C Burnham; J P Metlay; E A Halm; D E Singer
Journal:  Arch Intern Med       Date:  1998-06-22
View more
  6 in total

1.  Population-based cohort study of outpatients with pneumonia: rationale, design and baseline characteristics.

Authors:  Dean T Eurich; Sumit R Majumdar; Thomas J Marrie
Journal:  BMC Infect Dis       Date:  2012-06-18       Impact factor: 3.090

2.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

3.  Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective study.

Authors:  Geoffroy Hariri; Jacques Tankovic; Pierre-Yves Boëlle; Vincent Dubée; Guillaume Leblanc; Claire Pichereau; Simon Bourcier; Naike Bigé; Jean-Luc Baudel; Arnaud Galbois; Hafid Ait-Oufella; Eric Maury
Journal:  Ann Intensive Care       Date:  2017-03-24       Impact factor: 6.925

4.  Health promotion, risk stratification, and treatment options to decrease hospitalization rates for community-acquired pneumonia in adults.

Authors:  Cherese Severson; Collette Renstrom; Meg Fitzhugh
Journal:  J Am Assoc Nurse Pract       Date:  2013-09-03       Impact factor: 1.165

5.  Validating a novel index (SWAT-Bp) to predict mortality risk of community-acquired pneumonia in Malawi.

Authors:  Imogen M Buss; Edmund Birkhamshaw; Michael A Innes; Itai Magadoro; Peter I Waitt; Jamie Rylance
Journal:  Malawi Med J       Date:  2018-12       Impact factor: 0.875

6.  Death risk stratification in elderly patients with covid-19. A comparative cohort study in nursing homes outbreaks.

Authors:  M Bernabeu-Wittel; J E Ternero-Vega; P Díaz-Jiménez; C Conde-Guzmán; M D Nieto-Martín; L Moreno-Gaviño; J Delgado-Cuesta; M Rincón-Gómez; L Giménez-Miranda; M D Navarro-Amuedo; M M Muñoz-García; S Calzón-Fernández; M Ollero-Baturone
Journal:  Arch Gerontol Geriatr       Date:  2020-08-25       Impact factor: 4.163

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.